Biblio

Found 19 results
[ Author(Asc)] Keyword Title Type Year
Filters: First Letter Of Last Name is T  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
D. Trudel, Desmeules, P., Turcotte, S., Plante, M., Gregoire, J., Renaud, M. C., Orain, M., Bairati, I., and Tetu, B., Visual and automated assessment of matrix metalloproteinase-14 tissue expression for the evaluation of ovarian cancer prognosis, Mod Pathol, 2014.
B. Trimbos, Timmers, P., Pecorelli, S., Coens, C., Ven, K., van der Burg, M. E. L., and Casado, A., Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial., J Natl Cancer Inst, vol. 102, no. 13, pp. 982-7, 2010.
J. B. Trimbos, Vergote, I. B., Bolis, G., Vermorken, J. B., Mangioni, C., Madronal, C., Franchi, M., Tateo, S., Zanetta, G., Scarfone, G., Giurgea, L., Timmers, P., Coens, C., Pecorelli, S., Collaborators, E. O. R. T. C. - A. C. T. I. O. N., Research, E. Organisati, and Neoplasm, Tof Cancer-, Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial, J Natl Cancer Inst, vol. 95, pp. 113-25, 2003.
J. B. Trimbos, Parmar, M. K. B., Vergote, I. B., Guthrie, D., Bolis, G., Colombo, N., Vermorken, J. B., Torri, V., Mangioni, C., Pecorelli, S., Lissoni, A., Swart, A. Marie, Neoplasm, I. Collaborat, Research, E. Organisati, and Neoplasm, Tof Cancer, International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma, J Natl Cancer Inst, vol. 95, pp. 105-12, 2003.
E. L. Trimble, Birrer, M. J., Hoskins, W. J., Marth, C., Petryshyn, R., Quinn, M., Thomas, G. M., Kitchener, H. C., Aghajanian, C., Alberts, D. S., Armstrong, D., Brown, J., Coleman, R. L., Colombo, N., Eisenhauer, E., Friedlander, M. Leonard, Fujiwara, K., Hunsberger, S., Kaye, S. B., Ledermann, J. A., Lee, S., Look, K., Mannel, R., McNeish, I. A., Minasian, L. M., Oza, A. M., Paul, J., Poveda, A. M., Pujade-Lauraine, E., Schoenfeldt, M., Swart, A. Marie, von Gruenigen, V., and Wenzel, L. B., Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009., Int J Gynecol Cancer, vol. 20, no. 7, pp. 1290-8, 2010.
E. L. Trimble, Ledermann, J. A., Law, K., Miyata, T., Imamura, C. K., Nam, B. - H., Kim, Y. H., Bang, Y. - J., Michaels, M., Ardron, D., Amano, S., Ando, Y., Tominaga, T., Kurokawa, K., and Takebe, N., International models of investigator-initiated trials: implications for Japan., Ann Oncol, vol. 23, no. 12, pp. 3151-5, 2012.
C. L. Trimble, Kauderer, J., Zaino, R., Silverberg, S., Lim, P. C., ,, Alberts, D. S., and Curtin, J., Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study, Cancer, vol. 106, pp. 812-9, 2006.
F. Trillsch, Mahner, S., Woelber, L., Vettorazzi, E., Reuss, A., Ewald-Riegler, N., de Gregorio, N., Fotopoulou, C., Schmalfeldt, B., Burges, A., Hilpert, F., Fehm, T., Meier, W., Hillemanns, P., Hanker, L., Hasenburg, A., Strauss, H. G., Hellriegel, M., Wimberger, P., Baumann, K. H., Keyver-Paik, M. D., Canzler, U., Wollschlaeger, K., Forner, D., Pfisterer, J., Schröder, W., Muenstedt, K., Richter, B., Kommoss, F., Hauptmann, S., and du Bois, A., Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: Results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study, Ann Oncol, vol. 25, pp. 1320-7, 2014.
O. Tredan, Geay, J. - F., Touzet, S., Delva, R., Weber, B., Cretin, J., Provencal, J., Martin, J., Stefani, L., Pujade-Lauraine, E., Freyer, G., and Ovariens, Gd'Investig, Carboplatin/cyclophosphamide or carboplatin/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, Ann Oncol, vol. 18, pp. 256-62, 2007.
T. Toita, Kato, S., Ishikura, S., Tsujino, K., Kodaira, T., Uno, T., Hatano, K., Sakurai, H., Niibe, Y., Kazumoto, T., Nishimura, T., Kitagawa, R., Fukutani, M., Oguchi, M., Umayahara, K., Hirashima, Y., Aoki, Y., Takizawa, K., and Group, D. Committee, Radiotherapy quality assurance of the Japanese Gynecologic Oncology Group study (JGOG1066): a cooperative phase II study of concurrent chemoradiotherapy for uterine cervical cancer, Int J Clin Oncol, vol. 16, pp. 379-86, 2011.
T. Toita, Kitagawa, R., Hamano, T., Umayahara, K., Hirashima, Y., Aoki, Y., Oguchi, M., Mikami, M., Takizawa, K., and Group, C. Cancer Vul, Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG, Int J Gynecol Cancer, vol. 22, pp. 1420-6, 2012.
T. Toita, Kitagawa, R., Hamano, T., Umayahara, K., Hirashima, Y., Aoki, Y., Oguchi, M., Mikami, M., Takizawa, K., and Group, C. Cancer Com, Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule, Gynecol Oncol, vol. 126, pp. 211-6, 2012.
J. T. Thigpen, Bertelsen, K., Eisenhauer, E., Hacker, N. F., Lund, B., and Sessa, C., Long-term follow-up of patients with advanced ovarian carcinoma treated with chemotherapy., Ann Oncol, vol. 4 Suppl 4, pp. 35-40, 1993.
T. Thigpen, Stuart, G. C. E., du Bois, A., Friedlander, M. Leonard, Fujiwara, K., Guastalla, J. P., Kaye, S. B., Kitchener, H. C., Kristensen, G. B., Mannel, R., Meier, W., Miller, B., Poveda, A. M., Provencher, D. M., Stehman, F. B., Vergote, I. B., InterGroup, G. Cancer, ,, -CTG, N. C. I. C., -OVAR, A. G. O., ,, ,, ,, ,, /NCRI, M. R. C., ,, ,, ,, and , Clinical trials in ovarian carcinoma: Requirements for standard approaches and regimens, Ann Oncol, vol. 16 Suppl 8, pp. viii13-viii19, 2005.
T. Thigpen, du Bois, A., McAlpine, J., DiSaia, P., Fujiwara, K., Hoskins, W. J., Kristensen, G. B., Mannel, R., Markman, M., Pfisterer, J., Quinn, M., Reed, N. Simon, Swart, A. Marie, Berek, J. S., Colombo, N., Freyer, G., Gallardo, D., Plante, M., Poveda, A. M., Rubinstein, L., Bacon, M., Kitchener, H. C., and Stuart, G. C. E., First-line therapy in ovarian cancer trials., Int J Gynecol Cancer, vol. 21, no. 4, pp. 756-62, 2011.
T. Thigpen, Stuart, G. C. E., du Bois, A., Friedlander, M. Leonard, Fujiwara, K., Guastalla, J. P., Kaye, S. B., Kitchener, H. C., Kristensen, G. B., Mannel, R., Meier, W., Miller, B., Poveda, A. M., Provencher, D. M., Stehman, F. B., and Vergote, I. B., Clinical trials in ovarian carcinoma: requirements for standard approaches and regimens., Ann Oncol, vol. 16 Suppl 8, pp. viii13-viii19, 2005.
K. S. Tewari, Sill, M. W., Long, H. J., Penson, R. T., Huang, H., Ramondetta, L. M., Landrum, L. M., Oaknin, A., Reid, T. J., Leitao, M. M., Michael, H. E., and Monk, B. J., Improved survival with bevacizumab in advanced cervical cancer., N Engl J Med, vol. 370, no. 8, pp. 734-43, 2014.
S. Temkin, Tanner, E. J., Dewdney, S., and Minasian, L. M., Reducing overtreatment in gynecologic oncology: the case for less in endometrial and ovarian cancer, Frontiers in Oncology , vol. 6, no. 00118 , 2016.
S. Takakura, Takano, M., Takahashi, F., Saito, T., Aoki, D., Inaba, N., Noda, K., Sugiyama, T., Ochiai, K., and Group, J. Gynecologi, Randomized phase II trial of paclitaxel plus carboplatin therapy versus irinotecan plus cisplatin therapy as first-line chemotherapy for clear cell adenocarcinoma of the ovary: a JGOG study, Int J Gynecol Cancer, vol. 20, pp. 240-7, 2010.